Imed Infinity Medical-Limited Partnership
Tel Aviv Stock Exchange IMED.TA
Imed Infinity Medical-Limited Partnership Free Cash Flow Yield on January 13, 2025
Imed Infinity Medical-Limited Partnership Free Cash Flow Yield is NA on January 13, 2025, a NA change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
-
Imed Infinity Medical-Limited Partnership 52-week high Free Cash Flow Yield is NA on January 13, 2025, which is NA below the current Free Cash Flow Yield.
-
Imed Infinity Medical-Limited Partnership 52-week low Free Cash Flow Yield is NA on January 13, 2025, which is NA below the current Free Cash Flow Yield.
-
Imed Infinity Medical-Limited Partnership average Free Cash Flow Yield for the last 52 weeks is NA.
Key data
| Date | Free Cash Flow Yield | Market Value Added (MVA) | Price to Book Ratio (P/B) | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: IMED.TA
| CEO | Mr. Itay Gal-Or |
| IPO Date | Jan. 4, 2021 |
| Location | Israel |
| Headquarters | Azrieli Tower |
| Employees | 55 |
| Sector | Industrials |
| Industries | |
Description
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email